LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”

Photo by schluditsch from unsplash

8. Gallo G, Mastorino L, Tonella L, Ribero S, Quaglino P. Alopecia areata after COVID-19 vaccination. Clin Exp Vaccine Res 2022; 11: 129-32. 9. Aryanian Z, Balighi K, Hatami P,… Click to show full abstract

8. Gallo G, Mastorino L, Tonella L, Ribero S, Quaglino P. Alopecia areata after COVID-19 vaccination. Clin Exp Vaccine Res 2022; 11: 129-32. 9. Aryanian Z, Balighi K, Hatami P, Afshar ZM, Mohandesi NA. The role of SARS-CoV-2 infection and its vaccines in various types of hair loss. Dermatol Ther 2022; 35: e15433. 10. Perricone C, Colafrancesco S, Mazor RD, Soriano A, AgmonLevin N, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun 2013; 47: 1-16.

Keywords: drug reaction; severe lichenoid; reaction pembrolizumab; rechallenge severe; lichenoid drug; successful rechallenge

Journal Title: European Journal of Dermatology
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.